My Daily Brief

My Daily Brief

Investment Research Report: Applied Materials (AMAT)

MDB Research's avatar
MDB Research
May 12, 2026
∙ Paid

Applied Materials is the world’s largest semiconductor equipment company with FY2025 revenue of $28.4B, positioned at the intersection of every critical technology transition in chipmaking: Gate-All-Around transistors at 2nm, High-Bandwidth Memory for AI, advanced packaging, and backside power delivery. The company reported a strong Q1 FY2026 with revenue of $7.01B (beat consensus), guided Q2 to a record $7.65B, and management projects >20% growth in AMAT’s semiconductor equipment business in CY2026.

The investment thesis centers on an earnings inflection now underway. Consensus EPS estimates have risen +15-19% over 90 days across all periods (current year $11.11, next year $14.39), driven by stabilizing China revenue (now at 30%, down from 37%) and accelerating non-China growth (~17% YoY). At ~29x next-year earnings, AMAT trades at a discount to semiconductor equipment peers, with comparable or superior growth profiles.

The key near-term risk is the Trump-Xi summit scheduled for May 14-15. AMAT derives 30% of revenue from China, and the options market appears to be pricing this binary event aggressively. The stock has appreciated 164% from its May 2025 lows, making position sizing and entry timing important considerations.

Company Overview

Applied Materials operates two primary segments: Semiconductor Systems (73% of revenue), providing capital equipment for wafer fabrication across etch, deposition, thermal processing, CMP, metrology, and ion implantation; and Applied Global Services (23% of FY2025 revenue), delivering spares, services, and subscription-based factory automation solutions to its installed base.

The company’s geographic revenue mix is highly concentrated in Asia-Pacific (86% of FY2025 revenue): China 30%, Taiwan 24%, Korea 20%, Japan 8%, Southeast Asia 4%. This concentration reflects the physical reality that virtually all advanced chip manufacturing occurs in Asia, making it both the source of growth and the primary axis of geopolitical risk.

AMAT’s competitive differentiation lies in materials engineering breadth. As transistor architectures shift from FinFET to Gate-All-Around and chip stacking becomes standard (HBM, 3D NAND, advanced packaging), the number of materials engineering process steps per wafer increases substantially. AMAT’s addressable market grows with complexity.

Financial Analysis

Revenue Trajectory: FY2025 revenue of $28.4B grew 4.4% YoY — a misleading figure. China revenue declined 16% ($10.1B to $8.5B), masking ex-China growth of approximately 17% ($17.1B to $19.9B). Q1 FY2026 revenue of $7.01B was down 2% YoY, with China declining 7% and several other geographies also lower; Q2 guidance of $7.65B (+9% sequential, +8% YoY) represents the inflection as the China headwind annualizes.

Margin Expansion: Gross margin expanded from 47.5% (FY2024) to 49.0% (Q1 FY2026). AMAT’s 10-K attributes this improvement primarily to higher revenue, favorable customer/product mix, higher average selling prices, and lower material/manufacturing costs. This approximately 150 bps expansion on a $28B+ revenue base represents ~$420M of incremental gross profit annually. Operating margins (non-GAAP) have held near 30%.

Cash Generation: FY2025 operating cash flow was $8.0B (28% margin). Free cash flow of ~$5.7B was constrained by elevated capex of $2.3B (nearly doubled YoY) as the company builds its new Equipment and Process Innovation Center. Q1 FY2026 FCF was $1.04B, up 91% YoY from $544M — driven by stronger operating cash flow generation (capex actually increased YoY to $646M from $381M).

Balance Sheet: Net cash position with $13.5B in cash/investments vs. $6.5B long-term debt. Altman Z-Score of 3.52 (safe). Current ratio 2.61. ROE 34.3%. The balance sheet provides substantial flexibility for capital returns ($13.6B buyback authorization remaining) and continued R&D investment.

Capital Returns: $6.3B returned to shareholders in FY2025 ($4.9B buybacks + $1.4B dividends), representing 110% of FCF. Buyback pace slowed in Q1 FY2026 ($337M vs. $1.3B a year ago) — this may reflect greater valuation discipline at higher stock prices, though AMAT has not publicly stated the rationale.

Growth Analysis

The growth thesis rests on three converging pillars:

1. Secular Equipment Intensity Increase: The semiconductor industry is projected to reach $1T in CY2026 revenue. More critically for AMAT, management expects AMAT’s semiconductor equipment business to grow over 20% in CY2026. Each new node requires more materials engineering steps: GAA transistors at 2nm require more deposition and etch steps than FinFET. Advanced packaging for AI (HBM, 2.5D/3D integration) adds entirely new equipment demand layers.

2. DRAM/HBM Revenue Surge: DRAM mix within Semiconductor Systems surged to 34% in Q1 FY2026 (from 27% YoY), which management attributed to higher memory spending due to DRAM technology transitions. HBM production requires AMAT’s etch and deposition tools for 3D stacking, and every AI GPU/accelerator requires multiple HBM stacks. This is a direct, measurable transmission mechanism from AI capex to AMAT revenue.

3. China Headwind Annualization: China revenue was approximately $2.1B in Q1 FY2026 (30% of total), down 7% YoY. Management has characterized China as approaching a more normalized level. Once this base-effect fully annualizes in Q2-Q3 FY2026, reported growth rates should converge with ex-China growth of ~17%.

Estimate Revisions: Current quarter EPS estimates have risen 17.8% over 90 days ($2.28 → $2.68). Next year EPS has risen 18.8% ($12.11 → $14.39). These revision trends, while strong at +15-19%, fall below the +30% threshold that constitutes the strongest BUY signal. However, they are directionally powerful and accelerating (30-day revisions positive across all periods).

Management Guidance: Q2 FY2026 revenue guided to $7.65B ± $500M, representing record quarterly revenue at the midpoint. Non-GAAP EPS guided to $2.64 ± $0.20 ($2.44-$2.84).

Valuation Assessment

AMAT trades at $421.80. Relevant valuation metrics:

  • Trailing-twelve-month P/E of approximately 43x (based on estimated TTM EPS of ~$9.75 after Q1 FY2026, which includes the $253M BIS settlement charge recorded in Q1 FY2026)

  • FY2025 P/E of approximately 49x (based on FY2025 diluted EPS of $8.66)

  • ~38x forward P/E on current year consensus of $11.11

  • ~29.3x forward P/E on next year consensus of $14.39

  • PEG ratio of approximately 1.1x (using ~26% expected EPS growth)

Peer Comparison: AMAT trades at a discount to direct semiconductor equipment peers on a forward P/E basis. However, precise peer comparisons depend on whether trailing or forward multiples are used and the specific data date:

  • Lam Research (LRCX): trailing P/E ~49x, forward P/E ~33x

  • KLA Corp (KLAC): trailing P/E ~43x, forward P/E ~29x

  • Teradyne (TER): trailing P/E elevated (~66x), forward P/E ~46x

On a forward P/E basis, AMAT at ~29x next-year earnings trades at a modest discount to Lam (~33x forward) and a more meaningful discount to Teradyne (~46x forward), while appearing roughly in line with KLA (~29x forward). The discount is most pronounced on a trailing basis, where AMAT’s ~43x compares to Lam’s ~49x and Teradyne’s ~66x. The valuation gap partially reflects AMAT’s higher China exposure and recent BIS settlement overhang.

Why the Market May Be Wrong: The discount to peers may be disproportionate to the actual China risk. The secular drivers (GAA, HBM, advanced packaging) benefit AMAT’s non-China revenue, which grew 17% in FY2025 and is accelerating. As China revenue normalizes and total growth accelerates toward the 15-20% range, multiple expansion toward the upper end of peer levels represents meaningful upside.

Analyst Targets: Consensus median $445, mean $439, range $280-$550. The stock at $421.80 is 5% below median consensus. Given the revision trend (+15-19% over 90 days), these targets are likely stale and will be revised higher following Q2 results.

The valuation score of 5.0 reflects the tension between relative cheapness (vs. peers on trailing basis) and absolute level (29x forward is not cheap in isolation, particularly with geopolitical binary risks that could compress the multiple if export controls escalate).

Competitive Landscape

AMAT holds the broadest product portfolio in semiconductor equipment, spanning more process steps than any competitor. This breadth becomes increasingly valuable as technology complexity rises — chipmakers prefer integrated solutions that reduce process integration risk.

Competitive Position — Strengthening:

  • Gate-All-Around transistors require materials engineering capabilities that are AMAT’s core competency

  • HBM stacking uses AMAT’s etch and deposition tools — DRAM mix rose to 34% (from 27% YoY), suggesting AMAT is capturing meaningful share of HBM-related spending

  • Advanced packaging is a new TAM addition where AMAT has early leadership

  • Backside Power Delivery: New architecture enabling better chip performance

Competitive Threats:

  • Chinese domestic equipment makers are developing alternatives for mature-node fabrication, supported by government policy. This threatens the non-leading-edge portion of AMAT’s China business.

  • ASML’s EUV monopoly captures a disproportionate share of leading-edge capex — some AI spending goes to lithography rather than materials engineering.

  • Lam Research and Tokyo Electron overlap in etch and deposition, maintaining pricing discipline but limiting AMAT’s ability to expand share within specific process steps.

The trajectory of competitive position is stable-to-improving as technology complexity increases, with the key risk being permanent displacement in China’s domestic market.

Risk Assessment

1. Export Control Escalation (CRITICAL, NEAR-TERM): The Trump-Xi summit is scheduled for May 14-15. Reports indicate export controls may be discussed, though the precise agenda items are not fully confirmed by publicly available sources. An adverse outcome could produce new restrictions affecting AMAT’s $8.5B China revenue. The suspended denial order from the BIS settlement adds a compliance dimension — any misstep within 3 years could trigger export prohibition.

2. Cyclical Correction Risk (ELEVATED): The semiconductor equipment sector has risen dramatically. Retail call buying in Mag 10 names is at 2021 levels. SOX has risen 50% in 25 trading days. Historical pattern: retail euphoria of this magnitude preceded drawdowns within 2-6 weeks. A 10-15% correction in the SOX would drag AMAT proportionally.

3. AI Demand Uncertainty: Management’s 10-K explicitly warns AI investment “timing and amount can change significantly.” If hyperscaler capex decelerates or AI use cases fail to monetize, the >20% growth projection for CY2026 could prove too optimistic.

4. Rare Earth Supply Chain: China’s 2025 rare earth export controls affect AMAT’s manufacturing. Further restrictions could constrain production capability.

5. Customer Concentration: Two customers represent 35% of Q1 FY2026 revenue (likely TSMC and Samsung/SK Hynix).


This publication is for informational and educational purposes only and does not constitute financial, investment, or trading advice. The analysis, opinions, and commentary presented here should not be interpreted as a recommendation to buy, sell, or hold any security. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.

Option Market Signals, Investment Thesis, Investment Horizon and Exit Criteria below, for subscribers.

User's avatar

Continue reading this post for free, courtesy of MDB Research.

Or purchase a paid subscription.
© 2026 Daniele Malleo · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture